SGK1 was reported to be up-regulated in both AML, CML, and B-cell lymphoma, and has been shown to play a role in both chemotherapy resistance and radio-resistance due to its structural similarities to AKT24,25. Here, SGK1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.